| Q1 | Q2 | Q3 | Q4 | P-value |
---|---|---|---|---|---|
N | 945 | 946 | 947 | 947 | Â |
Sociodemographic variables | Â | Â | Â | Â | Â |
Age (years) | 46.44 ± 0.56 | 49.20 ± 0.57 | 51.58 ± 0.57 | 51.81 ± 0.58 | < 0.001 |
Gender | Â | Â | Â | Â | 0.828 |
Male | 466 (49.31%) | 457 (48.31%) | 461 (48.68%) | 447 (47.20%) | Â |
Female | 479 (50.69%) | 489 (51.69%) | 486 (51.32%) | 500 (52.80%) | Â |
Race/Ethnicity (%) |  |  |  |  | < 0.001 |
Mexican American | 155 (16.40%) | 196 (20.72%) | 239 (25.24%) | 255 (26.93%) | Â |
Other Hispanic | 112 (11.85%) | 100 (10.57%) | 82 (8.66%) | 45 (4.75%) | Â |
Non-Hispanic White | 396 (41.90%) | 441 (46.62%) | 461 (48.68%) | 516 (54.49%) | Â |
Non-Hispanic Black | 197 (20.85%) | 177 (18.71%) | 150 (15.84%) | 111 (11.72%) | Â |
Other race/ethnicity | 85 (8.99%) | 32 (3.38%) | 15 (1.58%) | 20 (2.11%) | Â |
Education level (%) |  |  |  |  | < 0.001 |
Less than high school | 244 (25.82%) | 282 (29.81%) | 347 (36.64%) | 330 (34.85%) | Â |
High school or GED | 172 (18.20%) | 216 (22.83%) | 213 (22.49%) | 244 (25.77%) | Â |
Above high school | 529 (55.98%) | 448 (47.36%) | 387 (40.87%) | 373 (39.39%) | Â |
Poverty to income ratio | 2.57 ± 0.05 | 2.46 ± 0.05 | 2.46 ± 0.05 | 2.50 ± 0.05 | 0.443 |
Variables of laboratory data | Â | Â | Â | Â | Â |
ALT (IU/L) | 24.98 ± 0.57 | 27.45 ± 1.06 | 26.43 ± 0.77 | 27.39 ± 0.77 | 0.335 |
AST (IU/L) | 25.87 ± 0.45 | 27.42 ± 0.97 | 25.98 ± 0.69 | 25.05 ± 0.55 | < 0.001 |
SCr (µmol/L) | 74.27 ± 0.61 | 73.78 ± 0.69 | 69.40 ± 0.70 | 65.96 ± 0.75 | < 0.001 |
Total Cholesterol (mmol/L) | 4.71 ± 0.03 | 5.10 ± 0.03 | 5.24 ± 0.03 | 5.52 ± 0.04 | < 0.001 |
Triglyceride (mmol/L) | 0.99 ± 0.01 | 1.33 ± 0.02 | 1.57 ± 0.03 | 2.25 ± 0.06 | < 0.001 |
LDL-C (mmol/L) | 2.77 ± 0.03 | 3.09 ± 0.03 | 3.22 ± 0.86 | 3.34 ± 0.03 | < 0.001 |
HDL-C (mmol/L) | 1.49 ± 0.01 | 1.39 ± 0.01 | 1.32 ± 0.03 | 1.19 ± 0.01 | < 0.001 |
Serum uric acid (µmol/L) | 315.67 ± 2.59 | 325.33 ± 2.76 | 326.96 ± 2.80 | 325.68 ± 2.84 | 0.018 |
Serum albumin (g/L) | 42.77 ± 0.10 | 42.66 ± 0.10 | 43.44 ± 0.11 | 43.93 ± 0.10 | < 0.001 |
Albumin, urine (mg/L) | 11.94 ± 0.56 | 12.71 ± 0.64 | 13.28 ± 0.56 | 15.65 ± 0.71 | < 0.001 |
Creatinine, urine (mg/dl) | 125.69 ± 2.49 | 129.57 ± 2.54 | 133.88 ± 2.54 | 137.34 ± 2.72 | 0.009 |
Glycohemoglobin (%) | 5.58 ± 0.02 | 5.62 ± 0.02 | 5.62 ± 0.02 | 5.70 ± 0.039 | 0.123 |
eGFR (ml/min/1.73 m2) | 111.74 ± 1.07 | 109.44 ± 1.07 | 110.23 ± 1.06 | 110.28 ± 1.11 | 0.565 |
ACR (mg/g) | 10.01 ± 0.38 | 10.22 ± 0.39 | 10.63 ± 0.39 | 12.06 ± 0.45 | 0.001 |
Palmitelaidic acid (µmol/L) | 2.81 ± 0.03 | 4.19 ± 0.03 | 5.62 ± 0.04 | 9.19 ± 0.11 | < 0.001 |
Vaccenic acid (µmol/L) | 12.03 ± 0.10 | 19.70 ± 0.10 | 29.56 ± 0.16 | 55.59 ± 0.82 | < 0.001 |
Elaidic acid (µmol/L) | 9.04 ± 0.08 | 15.35 ± 0.10 | 24.40 ± 0.15 | 48.78 ± 0.69 | < 0.001 |
Linolelaidic acid (µmol/L) | 1.25 ± 0.01 | 1.69 ± 0.02 | 2.33 ± 0.02 | 3.73 ± 0.05 | < 0.001 |
Medical examination and personal life history | Â | Â | Â | Â | Â |
BMI (Kg/m2) | 27.64 ± 0.21 | 29.26 ± 0.21 | 29.18 ± 0.21 | 29.08 ± 0.20 | < 0.001 |
Waist circumference (cm) | 95.06 ± 0.50 | 98.93 ± 0.51 | 99.00 ± 0.51 | 99.15 ± 0.49 | < 0.001 |
SBP (mmHg) | 120.9 ± 0.58 | 122.1 ± 0.55 | 125.3 ± 0.61 | 126.7 ± 0.62 | < 0.001 |
DBP (mmHg) | 67.9 ± 0.40 | 69.9 ± 0.39 | 70.3 ± 0.45 | 71.6 ± 0.45 | < 0.001 |
Physical activity (MET-based rank) (%) |  |  |  |  | < 0.001 |
No physical activity | 317 (33.54%) | 353 (37.32%) | 320 (33.79%) | 288 (30.41%) | Â |
Low-intensity physical activity | 332 (35.13%) | 335 (35.41%) | 417 (44.03%) | 462 (48.79%) | Â |
High-intensity physical activity | 296 (31.32%) | 258 (27.27%) | 210 (22.18%) | 197 (20.80%) | Â |
Had at least 12 alcohol drinks/1 year? |  |  |  |  | < 0.001 |
Yes | 711 (75.24%) | 698 (73.78%) | 665 (70.22%) | 621 (65.58%) | Â |
No | 234 (24.76%) | 248 (26.22%) | 282 (29.78%) | 326 (34.42%) | Â |
Current cigarette use | Â | Â | Â | Â | 0.003 |
Every day | 358 (37.88%) | 367 (38.79%) | 350 (36.96%) | 359 (37.91%) | Â |
Some days | 97 (10.26%) | 82 (8.67%) | 53 (5.60%) | 62 (6.55%) | Â |
Not at all | 490 (51.85%) | 497 (52.54%) | 544 (57.44%) | 526 (55.54%) | Â |
Taking prescribed medicine for HBP |  |  |  |  | < 0.001 |
yes | 247 (26.14%) | 260 (27.48%) | 204 (21.54%) | 198 (20.91%) | Â |
No | 698 (73.86%) | 686 (72.52%) | 743 (78.46%) | 749 (79.09%) | Â |
Taking prescribed medicine for high cholesterol level | Â | Â | Â | Â | 0.002 |
Yes | 203 (21.48%) | 209 (22.09%) | 161 (17.00%) | 159 (16.79%) | Â |
No | 742 (78.52%) | 737 (77.91%) | 786 (83.00%) | 788 (83.21%) | Â |
Comorbidities (%) | Â | Â | Â | Â | Â |
Hypertension history | Â | Â | Â | Â | 0.136 |
Yes | 278 (29.42%) | 303 (32.03%) | 326 (34.42%) | 308 (32.52%) | Â |
No | 667 (70.58%) | 643 (67.97%) | 621 (65.58%) | 639 (67.48%) | Â |
NAFLD | Â | Â | Â | Â | 0.348 |
Yes | 101 (10.69%) | 97 (10.25%) | 99 (10.45%) | 119 (12.57%) | Â |
No | 844 (89.31%) | 849 (89.75%) | 848 (89.55%) | 828 (87.43%) | Â |
Diabetes history | Â | Â | Â | Â | 0.771 |
Yes | 84 (8.89%) | 70 (7.40%) | 88 (9.29%) | 80 (8.45%) | Â |
No | 848 (89.74%) | 860 (90.91%) | 842 (88.91%) | 854 (90.18%) | Â |
Border line | 13 (1.38%) | 16 (1.69%) | 17 (1.80%) | 13 (1.37%) | Â |
Coronary heart disease | Â | Â | Â | Â | 0.537 |
Yes | 29 (3.07%) | 28 (2.96%) | 38 (4.01%) | 35 (3.70%) | Â |
No | 916 (96.93%) | 918 (97.04%) | 909 (95.99%) | 912 (96.30%) | Â |